Medicare Advantage Is Turning Back Into an Operations Business
The easy read on Medicare Advantage this spring is that Washington just threw private insurers a lifeline. CMS finalized a 2.48% average payment increase for 2027, or more than $13 billion in additional payments, and the market responded exactly the way you would expect: managed-care stocks jumped. CVS then added fuel by raising its 2026 guidance after posting better-than-expected first-quarter results and tighter medical-cost control at Aetna.
That looks like a simple recovery story. It is not.
What casual readers are missing is that Medicare Advantage is becoming less of a political-rate business and more of an operations business. The same CMS announcement that improved the revenue outlook also made clear that the agency wants competition based on quality, not coding. It is excluding diagnosis information from unlinked chart reviews from risk-score calculations starting in 2027, and it explicitly said the impact will be bigger for plans that rely heavily on that practice. In other words, the government is raising the water level while quietly removing one of the easier ways insurers used to float higher.
That matters because the bullish case for health insurers over the last few weeks has been framed too loosely. Yes, first-quarter results were better. Reuters reported that major insurers signaled more stable medical costs after a long period of pressure. CVS said Aetna’s medical-loss ratio came in below analyst expectations, and management sounded confident enough to lift its full-year adjusted EPS range to $7.30 to $7.50. But that kind of improvement is only durable if the companies producing it are actually getting better at forecasting utilization, managing benefits, and moving members through care at lower administrative cost.
CMS itself is pointing toward that future. On May 13, the agency announced early adopters for its electronic prior-authorization push ahead of the January 1, 2027 deadline. The list included major health plans like Aetna, Humana, Elevance, and UnitedHealthcare, along with big health systems and EHR vendors such as Epic and Oracle. That is not a side story. It is the business model story. If prior authorization, claims documentation, and data exchange become more standardized and more observable, scale stops being just a membership advantage. It becomes a workflow advantage.
This is why I think the next phase of the managed-care trade will look more selective than the last one. A year ago, investors mostly needed a view on whether medical costs were blowing out and whether CMS would be generous enough. Now they need a view on which insurers can operate inside a tighter rulebook without giving back margin. Some plans will benefit from better rates and cleaner trends. Others will discover that a lot of their historic edge came from coding intensity, manual workarounds, and administrative friction that regulators are now targeting directly.
There is a second-order consequence here for employers and providers too. If the large national insurers get better at industrializing Medicare Advantage administration, they will carry those capabilities into adjacent businesses. Better prior-auth plumbing, cleaner claims data, and more accurate risk capture do not stay trapped inside one product line. They spread into Medicaid, commercial benefits, PBM coordination, and provider contracting. That means the winners in MA may not just post better earnings. They may widen the operating gap across the rest of healthcare.
So the interesting question is no longer whether CMS was soft or hard on insurers. The interesting question is which insurers can still grow when the government gives them more revenue with one hand and demands cleaner proof with the other. That is a much harder question, but it is the one that matters now.
The sector’s recent rebound may be real. I just would not confuse it with a return to the old playbook. Medicare Advantage is starting to reward insurers that can actually run the machine, not just price the policy.